Dexcom (DXCM) EBITDA Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,233.00 |
| Dec 31, 2025 | 736.00 |
| Sep 30, 2025 | 127.00 |
| Jun 30, 2025 | 337.00 |
| Mar 31, 2025 | 461.00 |
| Dec 31, 2024 | -497.00 |
| Sep 30, 2024 | 116.00 |
| Jun 30, 2024 | 1,597.00 |
| Mar 31, 2024 | 1,611.00 |
| Dec 31, 2023 | 6,966.00 |
| Sep 30, 2023 | 1,587.00 |
| Jun 30, 2023 | 1,672.00 |
| Mar 31, 2023 | 2,301.00 |
| Dec 31, 2022 | 995.00 |
| Sep 30, 2022 | 1,944.00 |
| Jun 30, 2022 | 1,903.00 |
| Mar 31, 2022 | 3,496.00 |
| Dec 31, 2021 | 365.00 |
| Sep 30, 2021 | 3,064.00 |
| Jun 30, 2021 | 3,161.00 |
| Mar 31, 2021 | 2,561.00 |
| Dec 31, 2020 | 1,706.00 |
| Sep 30, 2020 | 5,948.00 |
| Jun 30, 2020 | 1,887.00 |
| Mar 31, 2020 | 2,574.00 |
| Dec 31, 2019 | 2,008.00 |
| Sep 30, 2019 | 2,138.00 |
| Jun 30, 2019 | 973.00 |
| Mar 31, 2019 | 2,098.00 |
| Dec 31, 2018 | -4,425.00 |
| Sep 30, 2018 | 1,873.00 |
| Jun 30, 2018 | 2,587.00 |
| Mar 31, 2018 | 2,018.00 |
| Dec 31, 2017 | 3,035.00 |
| Sep 30, 2017 | 7,462.00 |
| Jun 30, 2017 | 5,458.00 |
| Mar 31, 2017 | 4,823.00 |
| Dec 31, 2016 | 5,105.00 |
| Sep 30, 2016 | 6,027.00 |
| Jun 30, 2016 | 1,989.00 |
| Mar 31, 2016 | 6,707.00 |
| Dec 31, 2015 | 6,451.00 |
| Sep 30, 2015 | 7,129.00 |
| Jun 30, 2015 | 9,174.00 |